DRKS00008185
Completed
Not Applicable
on-interventional study to evaluate neurotoxicity under therapy with Paclitaxel Omnicare for patients with various tumor entities - NEPA
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- C56
- Sponsor
- OMNICARE Pharma GmbH
- Enrollment
- 83
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Male and female patients \= 18 years
- •2\. Diagnosis of tumor disease for which a chemotherapy with Paclitaxel Omnicare is indicated
- •3\. Investigator's decision (independent of study participation) to treat the patient with Paclitaxel Omnicare®
- •4\. Sufficient patient's compliance upon investigator's assessment
- •5\. Written informed consent of the patient to retrospective and prospective pseudonomized documentation, to forwarding and analysis of the data and to access to the data within monitoring
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
on-interventional study to evaluate neurotoxicity under therapy with Docetaxel Omnicare for patients with various tumor entitiesC50C34C61C44C16Malignant neoplasm of breastMalignant neoplasm of bronchus and lungMalignant neoplasm of prostateOther malignant neoplasms of skinMalignant neoplasm of stomachDRKS00008183OMNICARE Pharma GmbH109
Active, not recruiting
Phase 1
Klinische Studie zur Überprüfung der Auswirkungen einer präoperativen Verabreichung von Glutamin und/oder Omega-3-Fettsäuren auf das Inflammationsgeschehen nach aortokoronaren Bypassoperationen - Inflammation-Bypassoperation-StudieIndikationsstellung für eine aortokoronare BypassoperationEUCTR2008-003971-30-ATniv.-Prof. Dr. Karlheinz Tscheliessnigg
Completed
Phase 3
A clinical trial to study the effect of two different radiotherapy treatment techniques in patients with cancer cervixHealth Condition 1: null- CARCINOMA CERVIXCTRI/2018/05/014021POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH80
Not yet recruiting
Phase 3
A Prospective randomized study to compare haematological toxicities and response between two different chemotherapy regimens in chemoradiotherapy treatment of carcinoma of uterine cervix.CTRI/2024/08/072198SRI VENKATESHWARA INSTITUTE OF MEDICAL SCIENCES
Active, not recruiting
Phase 1
The evaluation of safety and biological effects of cancer-killing virus vaccine given to patients with advanced brain tumoursMalignant neoplasm of brain, high-grade brain tumourCancerMalignant neoplasm of brainISRCTN51762486niversity of Leeds12